NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SpiroChem

SpiroChem

Private
BaselHealthcare & Life Scienceshttps://spirochem.com/

Last Round

VC Round

Dec 13, 2017

Total Funding Raised

$990,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SpiroChem is a contract research organization that provides chemistry services for drug discovery and process R&D to the life science industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

contract research organizationCROchemistry CROdrug discovery servicesmedicinal chemistryprocess R&Dsynthetic chemistrycomplex synthesisoutsourced R&Dhit-to-candidatelead optimizationroute scoutingcompound librariescomputational chemistryflow chemistrycatalog compounds

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SpiroChem Comparables

Compare SpiroChem with similar companies based on industry and business-model similarity.

SpiroChem comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioAscent
90%
Domainex Ltd
84%
GL CHEMTEC International
83%

SpiroChem Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 13, 2017
GrantMar 1, 2016
Convertible DebtSep 30, 2015
GrantJun 1, 2014
SeedJan 31, 2013
Accelerator
May 26, 2011

Key People

Founding team and executive leadership

Thomas Fessard

Co-Founder And CEO

Founding Team

Martin Birk

CFO

Executive Team

Florent Beaufils

Chief Operating Officer

Executive Team

SpiroChem Investors

Notable investors and investment history

SpiroChem investors
InvestorRounds
InnosuisseGrant
Venture KickAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors increased 120% MoM, reaching 10.9K.

  • May 4, 2025

    Monthly visitors grew 820% MoM, reaching 6.2K.

SpiroChem Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SpiroChem Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SpiroChem's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range71
Year Founded2011
Last FundingDec 13, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.